학술논문

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
Document Type
Article
Source
In: Stroke. (Stroke, 1 May 2020, 51(5):1546-1554)
Subject
Language
English
ISSN
15244628
00392499